Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,418 public trials 3,293 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Completed

A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer

NCT02005315

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Hospital Anschutz Cancer Pavillion Aurora, Colorado, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

NCT01189929

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Box Hill Hospital Box Hill, Victoria, Australia
  • The Austin Hospital Heidelberg, Victoria, Australia
  • Christchurch Hospital Christchurch, New Zealand
View Trial Details
Completed

A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer

NCT01189942

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
Locations
  • Sydney Cancer Centre Camperdown, New South Wales, Australia
  • Royal Brisbane & Women's Hospital Herston, Queensland, Australia
  • Ashford Cancer Centre Research Kurralta Park, South Australia, Australia
  • Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia
View Trial Details
Completed

A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)

NCT03289533

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Iizuka Hospital Iizuka, Fukuoka, Japan
  • Kindai University Hospital, Department of Gastroenterology and Hepatology Ōsaka-sayama, Osaka, Japan
  • National Cancer Center Hospital Chuo-ku, Tokyo, Japan
View Trial Details

Related conditions